Avalo Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 06/08/2026 | Mar 2026Filed 13/05/2026 | Sep 2025Filed 06/11/2025 | Jun 2025Filed 06/08/2026 | Mar 2025Filed 13/05/2026 | Sep 2024Filed 06/11/2025 | Jun 2024Filed 07/08/2025 | Mar 2024Filed 12/05/2025 |
|---|---|---|---|---|---|---|---|---|
| — | — | $0 | — | — | $0.2 | $0 | $0 | |
| −$36 | −$20 | −$31 | −$21 | −$13 | $23 | $98 | −$121 | |
| −$0.83 | −$0.98 | −$2.19 | −$1.92 | −$1.25 | −$2.83 | −$14.07 | −$141.14 | |
| 44 | 20 | 14 | 11 | 11 | 11 | 7.7 | 0.9 |
Trend